Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure and Chronic Kidney Disease: A Systematic Review
{{output}}
Introduction: To evaluate the cost-effectiveness of empagliflozin in patients with chronic heart failure with preserved ejection fraction (CHFpEF) and moderately reduced ejection fraction (CHFmrEF) across various healthcare syste... ...
